Cerus Corporation Reports Third Quarter 2014 Results
Cerus Corporation (NASDAQ:CERS) today announced financial results for the third quarter and nine months ended September 30, 2014.
“We saw increasing activity in the United States this quarter, as we initiated Expanded Access IDEs to provide INTERCEPT in response to the ongoing outbreaks of chikungunya, dengue and Ebola, as well as continuing to work with FDA on the reviews of our plasma and platelet PMAs," said William ‘Obi’ Greenman, Cerus’ president and chief executive officer.
Help employers find you! Check out all the jobs and post your resume.
“We saw increasing activity in the United States this quarter, as we initiated Expanded Access IDEs to provide INTERCEPT in response to the ongoing outbreaks of chikungunya, dengue and Ebola, as well as continuing to work with FDA on the reviews of our plasma and platelet PMAs," said William ‘Obi’ Greenman, Cerus’ president and chief executive officer.
Help employers find you! Check out all the jobs and post your resume.